Travere Therapeutics Inc. (TVTX)
Market Closed
17 Jul, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
56. 71
+1.43
+2.5868%
$
5.31B Market Cap
- P/E Ratio
- Div Yield
1.46M Volume
-3.18 Eps
$ 55.28
Previous Close 
Want to track TVTX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Travere Therapeutics Inc. (TVTX) Statistics
Valuation metrics
Market Cap 5.31B
Enterprise value 5.52B
Trailing P/E (ttm) -115.73
Forward P/E -
PEG ratio -0.55
Price/Sales (ttm) 9.84
Price/Book (mrq) 52.77
Enterprise Value/Revenue 10.3
Enterprise Value/EBITDA 143.31
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.45M
Average volume (90 days) 2.23M
Price summary
52-Week low 15.03
52-Week high 60.1
Beta -
50-Day moving average 52.45
200-Day moving average 34.97
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:9
Last split Date 2 Nov 2012
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.04%
Operating margin -0.11%
Operational effectiveness
Return on assets -0.04%
Return on equity -0.27%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 5.84
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.23
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 2.88
Total debt (mrq) -
Total Debt/Equity (mrq) 3.32
Current ratio (mrq) 3.13%
Book value per share (mrq) 1.07
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
